Equitherapie Rosinante ASBL
Equitherapie Rosinante reported revenue of 967 € for the 2022 financial year (annual accounts filed with the NBB on 29 Jun 2023).
The score of Equitherapie Rosinante shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2022
Change 2020 → 2022: Revenue +172 % Total assets +272 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Equitherapie Rosinante's annual accounts
Filed annual accounts
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 14 Jun 2022
- Year ended 31 Dec 2020filed on 30 May 2021
Equitherapie Rosinante's financial analysis
- Solvency62.9%sector median: 39.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Equitherapie Rosinante
Equitherapie Rosinante's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0819.409.082
- VAT number
- BE0819409082
- Peppol
- Registered · 0208:0819409082 · as of 10 Nov 2026
- Legal form
- ASBL
- Incorporated
- 01 Oct 2009
- Registered office
- 2230 Herselt
- Latest accounts
- 2022 · filed on 29 Jun 2023
- Activity
- Other miscellaneous personal service activities (NACE 96999)
Equitherapie Rosinante (ASBL) has been based in Herselt since 2009, active in: other miscellaneous personal service activities. For 2022, it reports revenue of 967 €, a net profit of 418 € and equity of 737 €. Its solvency stands at 62.9%, above the median of its sector (39.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Equitherapie Rosinante
Companies in the same business, of comparable size and area, outside its group.
- EuroVAprint Other personal service activities n.e.c. Ixelles · balance sheet 167,013 €
- Vzw Pompier Tuurken Other personal service activities n.e.c. Aalst · balance sheet 1,537 €
- Eerlijke Kost Samenaankoop Other personal service activities n.e.c. Schelle · balance sheet 3,022 €
- All For Climate ASBL Other business support service activities n.e.c. Brussels · balance sheet 922,159 €
- ONZE HONDENSCHOOL vzw Other personal service activities n.e.c. Kapellen · balance sheet 31,699 €
- Koninklijke Waak- en Verdedigingshond Hoboken Other personal service activities n.e.c. Antwerp · balance sheet 37,178 €
- Verenigde Hondenvrienden - Lille Other personal service activities n.e.c. Lille · balance sheet 40,413 €
- Asklepios Other business support service activities n.e.c. Zoersel · balance sheet 4,231 €
Frequently asked questions about Equitherapie Rosinante
What is the revenue of Equitherapie Rosinante?
According to the 2022 annual accounts filed with the NBB, the revenue of Equitherapie Rosinante amounts to 967 €.
What is the VAT number of Equitherapie Rosinante?
In Belgium, the VAT number is the company number prefixed with BE: BE0819409082 for Equitherapie Rosinante, if the company is VAT-registered. Its company number (CBE) is 0819.409.082.
Where is the registered office of Equitherapie Rosinante?
According to the CBE register, the registered office of Equitherapie Rosinante is in 2230 Herselt.
What is the equity of Equitherapie Rosinante?
At the close of the 2022 financial year, the equity of Equitherapie Rosinante amounts to 737 €, a solvency of 62.9% of total assets.
Who manages Equitherapie Rosinante?
The register lists 2 active mandates at Equitherapie Rosinante. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Equitherapie Rosinante
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →